PERSONALIZED-MEDICINE.

PERSONALIZED-MEDICINE.

Early Biomarker Testing Key for Perioperative NSCLC Success

A New Era in Lung Cancer Treatment The fight against nonsmall cell lung cancer (NSCLC) has taken a significant turn with the advent of early biomarker testing. This innovative approach is revolutionizing the way doctors diagnose and treat the disease, especially in the perioperative phase..

PERSONALIZED-MEDICINE.

Rx Rundown: Opella, Samsung Biologics, Dimension and more

Medical Marketing News, DealMaking, and Industry Chatter This week in the pharmaceutical industry has been a whirlwind of activity, with several significant developments making headlines..